• KOL
    • Diabetic Retinopathy
    • Lawrence S Morse
    • LAWRENCE S MORSE: Influence Statistics

      LAWRENCE S MORSE

      LAWRENCE S MORSE

      Show email address

      Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, USA. | Department of ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      LAWRENCE S MORSE:Expert Impact

      Concepts for whichLAWRENCE S MORSEhas direct influence:Diabetic retinopathy,Aids patients,Micropulse laser,Visual acuity,Optical coherence,Subretinal fluid,Fibroblast growth,Cytomegalovirus retinitis.

      LAWRENCE S MORSE:KOL impact

      Concepts related to the work of other authors for whichfor which LAWRENCE S MORSE has influence:Optical coherence,Diabetic retinopathy,Macular degeneration,Visual acuity,Retinal detachment,Cytomegalovirus retinitis,Laser photocoagulation.

      KOL Resume for LAWRENCE S MORSE

      Year
      2021

      Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, USA.

      2020

      Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, United States of America

      2019

      Department of Ophthalmology and Vision Science, University of California, Davis, Sacramento, California, USA

      2018

      Department of Ophthalmology, UC Davis Eye Center, Sacramento, CA, USA

      2017

      UC Davis Eye Center, University of California, Davis, Sacramento

      2016

      UC Davis Eye Center, University of California–Davis, Sacramento, California

      2015

      Department of Ophthalmology, University of California, Davis, Sacramento, California.

      2014

      From the University of California–Davis, Sacramento, California, USA

      Department of Ophthalmology, University of California-Davis Medical Center, Sacramento, California

      2013

      Department of Ophthalmology & Vision Science, University of California Davis, Davis, California

      2012

      Department of Ophthalmology and Vision Science, University of California Davis Health System Eye Center, 4860 Y Street, Suite 2400 Sacramento, CA 95817, USA

      2011

      From the Department of Ophthalmology and Vision Science, University of California Davis Eye Center, Sacramento, California.

      University of California Davis Eye Center, Sacramento, CA, USA

      2010

      From the Department of Ophthalmology and Vision Science, Davis Medical Center, University of California, Sacramento, California

      2009

      Department of Ophthalmology & Vision Science, University of California–Davis, Sacramento (Drs Lim, Tanimoto, Eliason, Brandt, Morse, and Park, and Mr Lum)

      2008

      Department of Ophthalmology and Vision Science, University of California Davis Medical Center, Sacramento, California

      2007

      From the Department of Ophthalmology and Vision Science, University of California, Davis Medical Center.

      2006

      Department of Ophthalmology & Vision Science, University of California—Davis, Sacramento, California

      2005

      Department of Ophthalmology, University of California-Davis, Sacramento, CA, USA

      2004

      From the Department of Ophthalmology and Molecular and Cellular Biology, University of California, Davis, California

      2001

      Department of Ophthalmology, University of California-Davis (L.S.M.), Davis, California, USA

      *Wilford Hall Medical Center, Lackland AFB, Texas; †University of Texas San Antonio; ‡University of California San Diego; §University of California Davis.

      2000

      Department of Ophthalmology, University of California Davis, Davis, California, USA

      1999

      Department of Ophthalmology, University of California, Davis (A.V.G., J.B.R., L.S.M.), Sacramento, California, USA

      1998

      Department of Ophthalmology, University of California, Davis, Sacramento, California, USA

      1997

      Department of Ophthalmology, University of California, Davis, Sacramento, California

      1996

      Department of Ophthalmology, University of California, Davis, Sacramento, 95816, USA.

      1995

      Department of Ophthalmology, University of California, Davis, Davis, California 95616

      1994

      Department of Ophthalmology, University of California, Davis, Sacramento.

      1992

      Retina Service, Department of Ophthalmology, University of California, Davis, Sacramento.

      1990

      The Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, 90024, USA

      Retinal Service, Department of Ophthalmology, University of California, Davis

      Duke University Eye Center, Durham.

      1989

      The Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine, 800 Westwood Plaza, Los Angeles, CA, 90024-1771, USA

      Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine.

      Sign-in to see all concepts, it's free!
      Sample of concepts for which LAWRENCE S MORSE is among the top experts in the world.
      Concept World rank
      pathophysiological role lipoproteins #1
      threshold rop dopamine #1
      substrate attachment factors #1
      apoptosis extrusion technique #1
      incidence cmvr #1
      subretinal hemorrhages #1
      premature infants dopamine #1
      increase intracellular production #1
      3 modern modalities #1
      micropulse lasers #1
      apoptotic raft #1
      armd preliminary data #1
      micrornas circulatory micrornas #1
      central macula instruments #1
      subthreshold 532 #1
      segmentation error rate #1
      logmar bcva cst #1
      circulatory mirnas #1
      frequency antivegf injections #1
      rop dopamine #1
      apoptosis membrane rafts #1
      cell death hrpe #1
      cmvr retinal #1
      areas laser irradiation #1
      fourierdomain oct rtvue #1
      culture factor viii #1
      retinitis specific #1
      radiation therapy armd #1
      19 eyes dme #1
      subsequent retinal detachments #1
      retinitis protease #1
      intraretinal environment #1
      hrpe cells areas #1
      injuries retinopathy #1
      dme comparable improvement #1
      compared stratus #1
      laser irradiation areas #1
      controversies cmv retinitis #1
      micropulse laser #1
      major cholesterol species #1
      1084 hiv patients #1
      hypolipidemic therapy statins #1
      Sign-in to see all concepts, it's free!

      Prominent publications by LAWRENCE S MORSE

      KOL-Index: 16447

      OBJECTIVE: This pilot study collected preliminary information on the effectiveness and safety of infrared (810-nm) diode laser macular grid photocoagulation in patients with nonexudative age-related macular degeneration (AMD). Results from this pilot study were used in designing a larger, multicenter, randomized clinical trial.

      DESIGN: A multicenter, randomized, controlled, clinical trial.

      PARTICIPANTS: A total of 229 eyes of 152 patients with AMD were enrolled in the pilot study. ...

      Known for Prophylactic Treatment | Laser Macular | Treated Eyes | Visual Acuity | Randomized Pilot
      KOL-Index: 15180

      Importance: Among adults with diabetes in the United States, severe forms of diabetic retinopathy (DR) are significantly associated with a greater vision-related functional burden.

      Objective: To assess the functional burden of DR across severity levels in the United States.

      Design, Setting, and Participants: This cross-sectional study was based on 1004 participants 40 years or older with diabetes and valid ocular and sociodemographic outcomes in the National Health and Nutrition ...

      Known for United States | Diabetic Retinopathy | Functional Burden | Severe Npdr | Adults Diabetes
      KOL-Index: 13453

      PURPOSE: To evaluate the association of subretinal hyperreflective material (SHRM) with visual acuity (VA), geographic atrophy (GA), and scar in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

      DESIGN: Prospective cohort study within a randomized clinical trial.

      PARTICIPANTS: The 1185 CATT participants.

      METHODS: Masked readers graded scar and GA on fundus photography and fluorescein angiography and graded SHRM on time-domain and spectral-domain (SD) optical ...

      Known for Eyes Shrm | Visual Acuity | Fluorescein Angiography | Hyperreflective Material | Degeneration Treatments
      KOL-Index: 12148

      OBJECTIVE: To evaluate the morphologic changes in the macula of subjects with repaired macula-off retinal detachment (RD) using high-resolution Fourier-domain optical coherence tomography (FD OCT) and to perform functional correlation in a subset of patients using microperimetry (MP-1).

      DESIGN: Prospective observational case series.

      PARTICIPANTS: Seventeen eyes from 17 subjects who had undergone anatomically successful repair for macula-off, rhegmatogenous RD at least 3 months earlier ...

      Known for Fd Oct | Retinal Detachment | Optical Coherence | Photoreceptor Disruption | Resolution Fourier
      KOL-Index: 11357

      OBJECTIVE: To compare baseline characteristics, treatment frequency, visual acuity (VA), and morphologic outcomes of eyes with >50% of the lesion composed of blood (B50 group) versus all other eyes (Other group) enrolled in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

      DESIGN: Prospective cohort study within a multicenter randomized clinical trial.

      PARTICIPANTS: CATT patients with neovascular age-related macular degeneration (AMD).

      METHODS: Treatment for ...

      Known for Macular Degeneration | 1 Year | Lesion Size | Treatments Trials | Visual Acuity
      KOL-Index: 11335

      PURPOSE: We studied the 3-year efficacy and safety results of a 4-year study evaluating fluocinolone acetonide (FA) intravitreal implants in eyes with persistent or recurrent diabetic macular edema (DME).

      DESIGN: Prospective, evaluator-masked, controlled, multicenter clinical trial.

      PARTICIPANTS: We included 196 eyes with refractory DME.

      METHODS: Patients were randomized 2:1 to receive 0.59-mg FA implant (n = 127) or standard of care (SOC additional laser or observation; n = 69). The ...

      Known for Diabetic Macular | Fluocinolone Acetonide | Intravitreal Implant | 6 Months | 2 Years
      KOL-Index: 11078

      PURPOSE: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections.

      METHODS: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, ...

      Known for Micropulse Laser | Diabetic Macular Edema | Intravitreal Injections | 12 Months | Visual Acuity
      KOL-Index: 10902

      OBJECTIVE: To characterize cytomegalovirus (CMV) retinitis in human immunodeficiency virus (HIV)-infected patients who demonstrate immune recovery while receiving highly active antiretroviral therapy (HAART).

      DESIGN: Consecutive, noncomparative case series.

      PARTICIPANTS: Twenty-two HIV-positive patients, from two institutions, with a history of CMV retinitis, and with elevated CD4 cell counts after HAART.

      MAIN OUTCOME MEASURES: Duration of healed CMV retinitis without anti-CMV therapy, ...

      Known for Immune Recovery | Cytomegalovirus Retinitis | Aids Patients | Anticmv Therapy | Highly Active
      KOL-Index: 9996

      OBJECTIVE: To determine if panretinal photocoagulation (PRP) alters retinal nerve fiber layer (RNFL) thickness and optic nerve appearance.

      METHODS: Patients with diabetes who did and did not undergo PRP and nondiabetic control subjects were enrolled in a prospective study. Participants underwent optical coherence tomography of the peripapillary retina and optic nerve. Stereoscopic optic nerve photographs were graded in a masked fashion.

      RESULTS: Ninety-four eyes of 48 healthy ...

      Known for Optic Nerve | Panretinal Photocoagulation | Diabetic Retinopathy | Fiber Layer | Eyes Prp
      KOL-Index: 9996

      AIM: To assess whether treatment of premature infants with dopamine is a risk factor for development of retinopathy of prematurity (ROP).

      METHODS: A retrospective case series analysis of two groups was utilised with a minimum follow up of 6 months. Clinical profiles and patient risk factors were identified along with an evaluation of ROP progression and an analysis of clinical outcome. All infants were seen in a single community neonatal intensive care unit (NICU). 41 consecutive high ...

      Known for Threshold Retinopathy | Infants Dopamine | Newborn Infant | Gestational Age | Prematurity Rop
      KOL-Index: 9776

      PURPOSE: To study the anatomic details of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration (AMD) using high-resolution Fourier-domain optical coherence tomography (Fd-OCT) and its three-dimensional reconstructions.

      METHODS: A Fd-OCT instrument was used to image five patients clinically diagnosed with RAP. A series of 100 raster-scanned B-scans centered over the macula was registered and rendered as a three-dimensional volume. These retinal ...

      Known for Optical Coherence | Angiomatous Proliferation | Resolution Fourier | Rap Lesions | Fd Oct
      KOL-Index: 9438

      PURPOSE: Phase-variance optical coherence tomography (PV-OCT) provides volumetric imaging of the retinal vasculature without the need for intravenous injection of a fluorophore. We compare images from PV-OCT and fluorescein angiography (FA) for normal individuals and patients with age-related macular degeneration (AMD) and diabetic retinopathy.

      DESIGN: This is an evaluation of a diagnostic technology.

      PARTICIPANTS: Four patients underwent comparative retinovascular imaging using FA and ...

      Known for Variance Optical | Pv Oct | Coherence Tomography | Fluorescein Angiography | Retinal Vasculature
      KOL-Index: 9344

      PURPOSE: To demonstrate the application of phase-variance optical coherence tomography (pvOCT) for contrast agent-free in vivo imaging of volumetric retinal microcirculation in the human foveal region and for extraction of foveal avascular zone dimensions.

      METHODS: A custom-built, high-speed Fourier-domain OCT retinal imaging system was used to image retinas of two healthy subjects and eight diabetic patients. Through the acquisition of multiple B-scans for each scan location, phase ...

      Known for Foveal Avascular Zone | Coherence Tomography | Variance Optical | Diabetic Patients | Retinal Imaging
      KOL-Index: 9098

      PURPOSE: To determine the prevalence of high myopia (HM), progressive high (degenerative) myopia (PHM), and myopic choroidal neovascularization (mCNV) in the United States.

      DESIGN: Cross-sectional study.

      PARTICIPANTS: Individuals aged 18 years and older participating in the National Health and Nutrition Examination Survey (NHANES) and patients aged 18 years and older seen in clinics participating in the American Academy of Ophthalmology's Intelligent Research in Sight (IRIS(®)) ...

      Known for United States | Choroidal Neovascularization | Prevalence Myopia | Iris Registry | 18 Years

      Key People For Diabetic Retinopathy

      Top KOLs in the world
      #1
      Ronald E Klein
      diabetic retinopathy beaver dam atherosclerosis risk
      #2
      Barbara E K Klein
      diabetic retinopathy beaver dam blood pressure
      #3
      Wong Tien Yin Wong
      diabetic retinopathy blood pressure retinal vascular caliber
      #4
      Matthew D Davis
      diabetic retinopathy visual acuity macular edema
      #5
      Lloyd Paul Aiello
      diabetic retinopathy visual acuity endothelial growth
      #6
      Frederick L III Ferris
      diabetic retinopathy visual acuity macular edema

      Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, USA. | Department of Ophthalmology and Vision Science, UC Davis Medical Center, Sacramento, CA 958

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.